Wilcken NR - Search Results

1

Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer.

Stockler M, Wilcken NR, Ghersi D, Simes RJ. Stockler M, et al. Among authors: wilcken nr. Cancer Treat Rev. 2000 Jun;26(3):151-68. doi: 10.1053/ctrv.1999.0161. Cancer Treat Rev. 2000. PMID: 10814559 Review.

2

Endocrine therapy for desmoid tumors.

Wilcken N, Tattersall MH. Wilcken N, et al. Cancer. 1991 Sep 15;68(6):1384-8. doi: 10.1002/1097-0142(19910915)68:6<1384::aid-cncr2820680634>3.0.co;2-f. Cancer. 1991. PMID: 1831400 Review.

3

Chemotherapy for metastatic breast cancer--when is enough enough?

Stockler M, Wilcken N, Coates A. Stockler M, et al. Eur J Cancer. 1997 Nov;33(13):2147-8. doi: 10.1016/s0959-8049(97)00257-8. Eur J Cancer. 1997. PMID: 9470799 No abstract available.

4

More on mammography.

Wilcken N, Ghersi D, Brunswick C, Clarke M, Ganz P. Wilcken N, et al. Lancet. 2000 Oct 7;356(9237):1275-6. doi: 10.1016/S0140-6736(05)73880-0. Lancet. 2000. PMID: 11072975 No abstract available.

5

Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.

Wilcken N, Hornbuckle J, Ghersi D. Wilcken N, et al. Cochrane Database Syst Rev. 2003;2003(2):CD002747. doi: 10.1002/14651858.CD002747. Cochrane Database Syst Rev. 2003. PMID: 12804433 Free PMC article. Review.

6

Taxane containing regimens for metastatic breast cancer.

Ghersi D, Wilcken N, Simes J, Donoghue E. Ghersi D, et al. Cochrane Database Syst Rev. 2003;(3):CD003366. doi: 10.1002/14651858.CD003366. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003366. doi: 10.1002/14651858.CD003366.pub2 PMID: 12917963 Updated. Review.

7

Fulvestrant: spreading the word, but not too thinly.

Wilcken NR, Stockler MR. Wilcken NR, et al. Lancet. 2003 Oct 18;362(9392):1254. doi: 10.1016/S0140-6736(03)14616-8. Lancet. 2003. PMID: 14575967 No abstract available.

8

Platinum containing regimens for metastatic breast cancer.

Carrick S, Ghersi D, Wilcken N, Simes J. Carrick S, et al. Cochrane Database Syst Rev. 2004;(2):CD003374. doi: 10.1002/14651858.CD003374.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2004;(3):CD003374. doi: 10.1002/14651858.CD003374.pub3 PMID: 15106201 Updated. Review.

9

Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer.

Nowak AK, Wilcken NR, Stockler MR, Hamilton A, Ghersi D. Nowak AK, et al. Among authors: wilcken nr. Lancet Oncol. 2004 Jun;5(6):372-80. doi: 10.1016/S1470-2045(04)01494-9. Lancet Oncol. 2004. PMID: 15172358 Review.

10

Platinum containing regimens for metastatic breast cancer.

Carrick S, Ghersi D, Wilcken N, Simes J. Carrick S, et al. Cochrane Database Syst Rev. 2004;(3):CD003374. doi: 10.1002/14651858.CD003374.pub3. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2017 Jun 23;6:CD003374. doi: 10.1002/14651858.CD003374.pub4 PMID: 15266482 Updated. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters